title: Comparative evaluation of cardiac markers in differentiated cells from menstrual blood and bone marrow-derived stem cells in vitro.
abstract: In recent years, menstrual blood-derived stem cells (MenSCs) have been introduced as easily accessible and refreshing stem cell source without ethical considerations in the field of regenerative medicine. The aim of this study was to investigate in vitro cardiac differentiation capacity of MenSCs compared to bone marrow-derived stem cells (BMSCs) under two protocols using 5-aza-2'-deoxycytidine (5-aza) and basic fibroblast growth factor (bFGF). Our data revealed that differentiated MenSCs and BMSCs acquired some features of cardiomyocytes; however, degree of differentiation was dependent on the protocol. In a similar manner with BMSCs, differentiated MenSCs showed upper levels of mRNA/protein of late-stage cardiac markers under 5-aza stimulation and continuous treatment with bFGF (protocol 2) compared to those induced by 5-aza alone (protocol 1) evidencing the key role of bFGF in cardiac development of stem cells. Compared to corresponding undifferentiated cells differentiated MenSCs under protocol 2 showed remarkable expression of connexin-43 and TNNT2 at both gene and protein levels, whereas developed BMSCs under the same condition only expressed connextin-43 at the higher level. Superiority of protocol 2 over protocol 1 was confirmed by assessment of LDH and cTnI production by differentiated cells. Based on the accumulative data, our study provided convincing evidence that MenSCs have relatively higher capability to be differentiated toward cardiomyocyte compared with BMSCs. Furthermore, usage of bFGF and 5-aza to induce in vitro cardiac differentiation of MenSCs is highly recommended.
authors.affiliation: Department of Animal Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.
authors.forename: Maryam
authors.initials: M
authors.lastname: Rahimi
authors.forename: Amir-Hassan
authors.initials: AH
authors.lastname: Zarnani
authors.forename: Homa
authors.initials: H
authors.lastname: Mohseni-Kouchesfehani
authors.forename: Haleh
authors.initials: H
authors.lastname: Soltanghoraei
authors.forename: Mohammad-Mehdi
authors.initials: MM
authors.lastname: Akhondi
authors.forename: Somaieh
authors.initials: S
authors.lastname: Kazemnejad
mesh_terms: D000328:Adult; D001374:Azacitidine / Q000031:analogs & derivatives / Q000494:pharmacology; D015415:Biomarkers / Q000378:metabolism*; D001773:Blood Cells / Q000166:cytology* / Q000378:metabolism; D001854:Bone Marrow Cells / Q000166:cytology* / Q000378:metabolism; D002454:Cell Differentiation / Q000187:drug effects; D000077209:Decitabine; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology; D006801:Humans; D008598:Menstruation / Q000097:blood* / Q000378:metabolism; D032383:Myocytes, Cardiac / Q000378:metabolism*; D013234:Stem Cells / Q000166:cytology* / Q000378:metabolism; D055815:Young Adult
chemical_list: D015415:Biomarkers; D016222:Fibroblast Growth Factor 2; D000077209:Decitabine; D001374:Azacitidine